FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GONAL-F (follitropin alfa) submitted by EMD Serono, Inc., typically to modify labeling or expand indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism
• Infertility

Drugs mentioned

• Gonal-F (follitropin alfa)

Snippet

SUPPL AP for GONAL-F (FOLLITROPIN ALFA)